Log in

Spero Therapeutics News Headlines (NASDAQ:SPRO)

$7.76
-0.32 (-3.96 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$7.17
Now: $7.76
$7.94
50-Day Range
$5.27
MA: $8.48
$10.41
52-Week Range
$5.25
Now: $7.76
$14.48
Volume47,203 shs
Average Volume116,466 shs
Market Capitalization$157.76 million
P/E RatioN/A
Dividend YieldN/A
Beta1.6

Headlines

Spero Therapeutics (NASDAQ SPRO) News Headlines

Source:
DateHeadline
Spero Therapeutics (NASDAQ:SPRO) Given Overweight Rating at Cantor FitzgeraldSpero Therapeutics (NASDAQ:SPRO) Given Overweight Rating at Cantor Fitzgerald
www.americanbankingnews.com - March 21 at 8:50 AM
Spero Therapeutics, Inc. Yearly Results Just Came Out: Heres What Analysts Are Forecasting For Next YearSpero Therapeutics, Inc. Yearly Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
finance.yahoo.com - March 18 at 9:12 PM
Spero Therapeutics, Inc. Yearly Results Just Came Out: Here's What Analysts Are Forecasting For Next YearSpero Therapeutics, Inc. Yearly Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
finance.yahoo.com - March 18 at 11:11 AM
Spero Therapeutics Inc (NASDAQ:SPRO) Given Average Recommendation of "Buy" by AnalystsSpero Therapeutics Inc (NASDAQ:SPRO) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - March 18 at 3:04 AM
Stifel Nicolaus Cuts Spero Therapeutics (NASDAQ:SPRO) Price Target to $21.00Stifel Nicolaus Cuts Spero Therapeutics (NASDAQ:SPRO) Price Target to $21.00
www.americanbankingnews.com - March 17 at 3:21 PM
Spero Therapeutics (NASDAQ:SPRO) Posts  Earnings Results, Misses Expectations By $0.27 EPSSpero Therapeutics (NASDAQ:SPRO) Posts Earnings Results, Misses Expectations By $0.27 EPS
www.americanbankingnews.com - March 17 at 7:14 AM
Spero Therapeutics EPS misses by $0.24, misses on revenueSpero Therapeutics EPS misses by $0.24, misses on revenue
seekingalpha.com - March 16 at 2:55 PM
Spero Therapeutics, Inc. (SPRO) Reports Q4 Loss, Tops Revenue EstimatesSpero Therapeutics, Inc. (SPRO) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 16 at 2:55 PM
Spero Therapeutics Inc (NASDAQ:SPRO) Short Interest Down 42.5% in FebruarySpero Therapeutics Inc (NASDAQ:SPRO) Short Interest Down 42.5% in February
www.americanbankingnews.com - March 13 at 10:56 PM
Spero Therapeutics Inc (NASDAQ:SPRO) Expected to Announce Quarterly Sales of $3.54 MillionSpero Therapeutics Inc (NASDAQ:SPRO) Expected to Announce Quarterly Sales of $3.54 Million
www.americanbankingnews.com - March 9 at 2:32 AM
Zacks: Analysts Expect Spero Therapeutics Inc (NASDAQ:SPRO) Will Announce Earnings of -$1.09 Per ShareZacks: Analysts Expect Spero Therapeutics Inc (NASDAQ:SPRO) Will Announce Earnings of -$1.09 Per Share
www.americanbankingnews.com - March 7 at 12:54 PM
Spero Therapeutics Announces Closing of Rights OfferingSpero Therapeutics Announces Closing of Rights Offering
finance.yahoo.com - March 5 at 7:59 PM
Earnings Preview: Spero Therapeutics, Inc. (SPRO) Q4 Earnings Expected to DeclineEarnings Preview: Spero Therapeutics, Inc. (SPRO) Q4 Earnings Expected to Decline
finance.yahoo.com - March 5 at 2:58 PM
Spero Therapeutics to Present at March Investor ConferencesSpero Therapeutics to Present at March Investor Conferences
finance.yahoo.com - February 26 at 5:46 PM
Spero launches rights offeringSpero launches rights offering
seekingalpha.com - February 11 at 2:58 PM
Spero Therapeutics Announces Commencement of Rights OfferingSpero Therapeutics Announces Commencement of Rights Offering
finance.yahoo.com - February 11 at 8:12 AM
BARDA OKs additional funding for development of Spero antibioticBARDA OKs additional funding for development of Spero antibiotic
seekingalpha.com - February 5 at 2:01 PM
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr DevelopmentSpero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development
finance.yahoo.com - February 5 at 8:59 AM
Spero readies $30M rights offeringSpero readies $30M rights offering
seekingalpha.com - January 30 at 1:41 PM
Spero Therapeutics Announces Proposed Rights OfferingSpero Therapeutics Announces Proposed Rights Offering
finance.yahoo.com - January 30 at 8:41 AM
Introducing Spero Therapeutics (NASDAQ:SPRO), A Stock That Climbed 11% In The Last YearIntroducing Spero Therapeutics (NASDAQ:SPRO), A Stock That Climbed 11% In The Last Year
finance.yahoo.com - January 16 at 12:10 PM
Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR206 and Plans to Advance Program with Alliance Partners Everest Medicines and the Department of DefenseSpero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR206 and Plans to Advance Program with Alliance Partners Everest Medicines and the Department of Defense
finance.yahoo.com - January 13 at 5:37 PM
Here is What Hedge Funds Think About Spero Therapeutics, Inc. (SPRO)Here is What Hedge Funds Think About Spero Therapeutics, Inc. (SPRO)
finance.yahoo.com - December 17 at 6:04 PM
Iterum Down as Sulopenem Antibiotic Fails in Phase III StudyIterum Down as Sulopenem Antibiotic Fails in Phase III Study
finance.yahoo.com - December 12 at 12:25 PM
Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary DiseaseSpero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary Disease
finance.yahoo.com - December 4 at 6:35 PM
Spero Therapeutics to Host Key Opinion Leader Symposium in DecemberSpero Therapeutics to Host Key Opinion Leader Symposium in December
finance.yahoo.com - November 26 at 9:01 AM
Infectiously Challenging - Speros Exciting ProgressInfectiously Challenging - Spero's Exciting Progress
seekingalpha.com - November 20 at 9:03 AM
BRIEF-Spero Therapeutics Announces Third Quarter 2019 Operating Results And Provides Pipeline ReviewBRIEF-Spero Therapeutics Announces Third Quarter 2019 Operating Results And Provides Pipeline Review
www.msn.com - November 5 at 10:24 PM
Spero Therapeutics Announces Third Quarter 2019 Operating Results and Provides Pipeline ReviewSpero Therapeutics Announces Third Quarter 2019 Operating Results and Provides Pipeline Review
finance.yahoo.com - November 4 at 7:51 PM
Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Tops Revenue EstimatesSpero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 4 at 7:51 PM
How Many Spero Therapeutics, Inc. (NASDAQ:SPRO) Shares Do Institutions Own?How Many Spero Therapeutics, Inc. (NASDAQ:SPRO) Shares Do Institutions Own?
finance.yahoo.com - October 23 at 1:44 PM
Spero Therapeutics Inc.Spero Therapeutics Inc.
www.barrons.com - October 11 at 9:35 PM
Spero Therapeutics (SPRO) Presents At Cantor Healthcare Conference - SlideshowSpero Therapeutics (SPRO) Presents At Cantor Healthcare Conference - Slideshow
seekingalpha.com - October 3 at 8:22 PM
Spero Therapeutics Announces Positive Recommendation to Continue Phase 3 Clinical Trial of SPR994 as Planned Following Independent Review Committee Analysis of SPR994 Treated Patients in Lead-in Cohort of TrialSpero Therapeutics Announces Positive Recommendation to Continue Phase 3 Clinical Trial of SPR994 as Planned Following Independent Review Committee Analysis of SPR994 Treated Patients in Lead-in Cohort of Trial
finance.yahoo.com - October 3 at 9:40 AM
Spero Therapeutics Announces Presentations at IDWeek 2019Spero Therapeutics Announces Presentations at IDWeek 2019
finance.yahoo.com - September 26 at 8:35 AM
Spero finance chief bids adieuSpero finance chief bids adieu
seekingalpha.com - September 6 at 2:19 PM
Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue EstimatesSpero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 9 at 12:49 AM
Spero Therapeutics Announces Second Quarter 2019 Operating Results and Provides Pipeline UpdateSpero Therapeutics Announces Second Quarter 2019 Operating Results and Provides Pipeline Update
finance.yahoo.com - August 8 at 7:46 PM
Spero Therapeutics, Inc. (SPRO) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseSpero Therapeutics, Inc. (SPRO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
finance.yahoo.com - August 1 at 7:38 PM
Spero nabs $5.9M DoD award to support SPR206; shares up 4%Spero nabs $5.9M DoD award to support SPR206; shares up 4%
seekingalpha.com - July 16 at 6:24 PM
Spero Therapeutics Announces $5.9 Million Award from U.S. Department of Defense to Further Clinical Development of SPR206Spero Therapeutics Announces $5.9 Million Award from U.S. Department of Defense to Further Clinical Development of SPR206
finance.yahoo.com - July 16 at 9:26 AM
Did Changing Sentiment Drive Spero Therapeutics's (NASDAQ:SPRO) Share Price Down By 15%?Did Changing Sentiment Drive Spero Therapeutics's (NASDAQ:SPRO) Share Price Down By 15%?
finance.yahoo.com - July 11 at 8:58 AM
Spero Therapeutics to Present Data for All Pipeline Programs at the ASM Microbe 2019 ConferenceSpero Therapeutics to Present Data for All Pipeline Programs at the ASM Microbe 2019 Conference
finance.yahoo.com - June 17 at 9:43 AM
Spero secures $10M capital raiseSpero secures $10M capital raise
seekingalpha.com - June 13 at 1:31 PM
Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue EstimatesSpero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 10 at 9:10 AM
Spero Therapeutics Announces First Quarter 2019 Operating Results and Provides Pipeline ReviewSpero Therapeutics Announces First Quarter 2019 Operating Results and Provides Pipeline Review
finance.yahoo.com - May 9 at 7:03 PM
Analysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - May 2 at 7:23 PM
Expedia Shares Fall as Home-Rental Business Vrbo Goes SlowExpedia Shares Fall as Home-Rental Business Vrbo Goes Slow
finance.yahoo.com - May 2 at 7:23 PM
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - May 1 at 8:57 AM
Spero Therapeutics Highlights SPR994 Data at the 29th European Congress of Clinical Microbiology and Infectious DiseasesSpero Therapeutics Highlights SPR994 Data at the 29th European Congress of Clinical Microbiology and Infectious Diseases
finance.yahoo.com - April 8 at 10:03 AM
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel